日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lactobacillus Restructures the Micro/Mycobiome to Combat Inflammation-Mediated Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.

乳酸杆菌重塑微生物/真菌群落,以对抗肺动脉高压中炎症介导的右心室功能障碍

Prisco Sasha Z, Blake Madelyn, Kazmirczak Felipe, Moon Ryan, Kremer Benjamin P, Hartweck Lynn M, Kim Minwoo, Vogel Neal, Mendelson Jenna B, Moutsoglou Daphne, Thenappan Thenappan, Prins Kurt W

Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension

微生物移植疗法对肺动脉高压患者安全可行

Moutsoglou, Daphne; Blake, Madelyn; Belhasan, Dina C; Peichel, Gretchen; Vang, Brenda M; Weir, E Kenneth; Lopez, Sharon; Prins, Kurt W; Kabage, Amanda J; Prisco, Sasha Z; Kremer, Benjamin P; Khoruts, Alexander; Thenappan, Thenappan